Osaka, Japan

Noritaka Koseki

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noritaka Koseki: Innovator in Heterocyclic Compounds

Introduction

Noritaka Koseki is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with therapeutic applications. His work focuses on enhancing platelet production through innovative chemical solutions.

Latest Patents

Koseki holds a patent for a heterocyclic compound that exhibits aryl hydrocarbon receptor antagonist activity. This compound is represented by a specific general formula and is useful for promoting platelet production. The patent highlights the potential of this compound in medical applications, showcasing Koseki's commitment to advancing healthcare solutions.

Career Highlights

Koseki is affiliated with Otsuka Pharmaceutical Company, Limited, where he continues to engage in groundbreaking research. His work at Otsuka has allowed him to explore various chemical compounds and their potential benefits in the pharmaceutical industry. His dedication to innovation is evident in his research and development efforts.

Collaborations

Throughout his career, Koseki has collaborated with notable colleagues, including Kazuhiro Ohdachi and Yusuke Fujimori. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of new technologies.

Conclusion

Noritaka Koseki is a distinguished inventor whose work in heterocyclic compounds has the potential to impact medical science significantly. His innovative approach and collaboration with esteemed colleagues highlight his contributions to the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…